Management of iatrogenic airway bleeding with flexible bronchoscopy: Evidence or experience-based?
Tuberk Toraks · 2023
DOI: 10.5578/tt.20239608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tuberk Toraks, 2023. Verfasst von Oğuz Karcıoğlu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chest Diseases, Hacettepe University Faculty of Medicine, Ankara, Türkiye. Hauptthemen laut MEDLINE: Bronchoscopy, Stroke. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Iatrogenic bleeding during bronchoscopy may lead to early termination, insufficient sample collection, decreased diagnostic accuracy, and even death. Unlike rigid bronchoscopy, the management of bleeding during flexible fiberoptic bronchoscopy does not allow the use of methods such as cautery, direct pressure, etc. and is usually limited to the application of liquids. The management of endobronchial bleeding usually depends on two main mechanisms: 1) vasoconstriction; 2) enhancing coagulation to form fibrin clots. The data on cold saline, the most widely recognized agent, is based on case reports and the experience of centers, not randomized controlled trials. Vasoconstrictor agents consist of adrenaline, vasopressin analogues, phenylephrine, and xylometazoline hydrochloride. However, there are only a limited number of randomized controlled trials on adrenaline, and information on the remaining substances is limited to retrospective studies, case reports, and expert opinions. The endobronchial administration of tranexamic acid, which inhibits fibrin degradation, has been the subject of very few studies. Despite its documented efficacy, information regarding its dosage, frequency of use, and safety is lacking. Although Ankaferd Blood Stopper, which binds erythrocytes to the vascular endothelium, has been shown to be effective in controlling bleeding related to dental procedures, the gastrointestinal tract, and operations, only one retrospective study found it to be effective against endobronchial bleeding that could not be controlled with cold saline and adrenaline. Although there are a variety of agents that centers use in their routine procedures, there is not yet a consensus on the efficacy, dose, frequency, and safety of any of them.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chest Diseases, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
Zitieren
APA
Karcıoğlu, O., & Selçuk, Z. T. (2023). Management of iatrogenic airway bleeding with flexible bronchoscopy: Evidence or experience-based?. Tuberk Toraks. https://doi.org/10.5578/tt.20239608
Vancouver
Karcıoğlu O, Selçuk ZT. Management of iatrogenic airway bleeding with flexible bronchoscopy: Evidence or experience-based?. Tuberk Toraks. 2023. doi:10.5578/tt.20239608
BibTeX
@article{Karcolu2023,
author = {Karcıoğlu, Oğuz and Selçuk, Ziya Toros},
title = {Management of iatrogenic airway bleeding with flexible bronchoscopy: Evidence or experience-based?},
journal = {Tuberk Toraks},
year = {2023},
doi = {10.5578/tt.20239608}
}
EUVIMED